| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,665 |
4,842 |
$220K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,811 |
1,529 |
$104K |
| 20610 |
|
2,252 |
1,324 |
$76K |
| 73630 |
|
783 |
577 |
$15K |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
92 |
49 |
$14K |
| 73610 |
|
543 |
437 |
$12K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
125 |
105 |
$9K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
67 |
60 |
$7K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,987 |
1,491 |
$3K |
| 73100 |
|
86 |
70 |
$2K |
| 73562 |
|
66 |
38 |
$1K |
| 73130 |
|
71 |
48 |
$948.66 |
| 73030 |
|
44 |
39 |
$851.63 |
| 73564 |
|
19 |
15 |
$468.66 |
| 73560 |
|
15 |
12 |
$332.04 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
163 |
133 |
$13.59 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
44 |
24 |
$6.16 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
315 |
265 |
$0.23 |